Registration Dossier

Administrative data

Endpoint:
short-term repeated dose toxicity: dermal
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
other:
Justification for type of information:
Additional repeated dose toxicity testing via dermal route is not applicable as a short-term as well as a subchronic repeated dose toxicity study are available via the oral route.
According to the REACH Regulation No. 1907/2006, Annex VIII, 8.6.1 and Annex IX 8.6.1as well as 8.6.2 only one repeated dose toxicity study is required, with test item administration via the most appropriate route having regard to human exposure. This is the case for the registered substance.

Data source

Materials and methods

Results and discussion

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion